Addressing the FDA's Performance, Efficiency, and Use of Resources: Hearings of the Committee on Labor and Human Resources, United States Senate, One Hundred Fifth Congress, First Session ... March 19 and April 11, 1997, Volume 4
U.S. Government Printing Office, 1997 - Drugs - 260 pages
What people are saying - Write a review
We haven't found any reviews in the usual places.
Other editions - View all
able action activities additional Administration agency agency's allow American applications appropriate approval approval process areas authority believe benefits better brand budget Center Chairman changes clinical committee companies concerns Congress consumers continue costs decisions discussion drug effective efficient efforts ensure establish example FDA's Federal Friedman funding goals going guidance hearing IMPACT important improve increase industry initiatives issues labeling legislation look manufacturers mean medical devices medicines meet months move Office patients PDUFA percent performance pharmaceutical practice prepared problems proposed protect public health question reading recent recognize reduce reform regulation regulatory represent requirements response result risk safe safety scientific Senator significant specific standards statement studies Thank things tion trials understand United user fees